Old Web
English
Sign In
Acemap
>
authorDetail
>
Malken Bayrakdarian
Malken Bayrakdarian
AstraZeneca
Chemistry
In vivo
Pharmacology
Biochemistry
Antagonist
4
Papers
49
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Discovery of P2X3 selective antagonists for the treatment of chronic pain
2012
Bioorganic & Medicinal Chemistry Letters
Louis-David Cantin
Malken Bayrakdarian
Christophe Buon
Eric Grazzini
Yun-Jin Hu
Jean Labrecque
Carmen Leung
Xuehong Luo
Giovanni Martino
Michel Paré
Kemal Payza
Nirvana Popovic
Denis Projean
Vijayaratnam Santhakumar
Christopher Walpole
Xiao Hong Yu
Miroslaw Tomaszewski
Show All
Source
Cite
Save
Citations (24)
Development of 2,4-diaminopyrimidine derivatives as novel SNSR4 antagonists
2011
Bioorganic & Medicinal Chemistry Letters
Malken Bayrakdarian
Joanne Butterworth
Yun-Jin Hu
Vijayaratnam Santhakumar
Miroslaw Tomaszewski
Show All
Source
Cite
Save
Citations (12)
Discovery and Pharmacological Characterization of a Small-Molecule Antagonist at Neuromedin U Receptor NMUR2
2009
Journal of Pharmacology and Experimental Therapeutics
Jay J. Liu
Kemal Payza
Jian Huang
Ruifeng Liu
Tongming Chen
Martin Coupal
Jennifer M.A. Laird
Chang-Qing Cao
Joanne Butterworth
Stéphanie Lapointe
Malken Bayrakdarian
Shephali Trivedi
J. Robert Bostwick
Show All
Source
Cite
Save
Citations (13)
Dérivés de pyrrolopyrimidin-7-one et leur utilisation comme produits pharmaceutiques
2008
Malken Bayrakdarian
Christophe Buon
Louis-David Cantin
Yun-Jin Hu
Xuehong Luo
Vijayaratnam Santhakumar
Miroslaw Tomaszewski
Show All
Source
Cite
Save
Citations (0)
1